SECreport

Form 3 TITAN PHARMACEUTICALS For: Apr 02 Filed by: Mokhtar Firdauz

Titan Pharmaceuticals, Inc.  (TTNP) 
NASDAQ:AMEX Investor Relations: ir.titanpharm.com